Clinical Trial Update: Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 trial examining how the initial levothyroxine dose affects neurodevelopment and growth in congenital hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Federico II University | Conditions: Congenital Hypothyroidism | Phase 4 | Status: COMPLETED